Clinical Trials · NCT01078805

Study of FORTEO Use in Subjects in the Community Setting

Phase
N/A
Recruitment status
Completed
Sponsor
Eli Lilly and Company
Enrollment
4,167
Start date
Aug 2003
Locations
1 site, United States
Primary endpoint
Percentage of Participants With Non-Vertebral Fragility Fractures
View Teriparatide compound reference